Back to Results
First PageMeta Content



Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines for
Add to Reading List

Document Date: 2010-12-21 11:17:55


Open Document

File Size: 60,77 KB

Share Result on Facebook